Related Experiment Video
Updated: Aug 10, 2026

Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis
Published on: January 26, 2015
Eosinophil granule proteins are selective activators of human heart mast cells
V Patella1, G de Crescenzo, I Marino
1Division of Clinical Immunology and Allergy, University of Naples Federico II, Italy.
Insights
Eosinophil cationic proteins, like ECP and MBP, activate human cardiac mast cells, releasing histamine and tryptase. This finding helps explain cardiac damage in eosinophilia patients.
Area of Science:
- Immunology
- Cardiology
- Cell Biology
Background:
- Eosinophilia involves eosinophil infiltration and cardiac deposition of granule proteins.
- Eosinophil granule proteins contribute to cardiac disease in some eosinophilia cases.
Purpose of the Study:
- To investigate the in vitro effects of four key eosinophil granule proteins on human cardiac mast cells.
- To determine which eosinophil proteins activate mast cells and mediate histamine and tryptase release.
Main Methods:
- Isolated human cardiac mast cells (HHMC) were exposed to eosinophil cationic protein (ECP), major basic protein (MBP), eosinophil-derived neurotoxin (EDN), and eosinophil peroxidase (EPO).
- Histamine and tryptase release were measured following protein exposure.
- Experiments included calcium and temperature dependency studies, antibody neutralization, and metabolic inhibition.
Main Results:
- ECP and MBP significantly stimulated histamine and tryptase release from HHMC.
- EDN and EPO did not induce mast cell activation.
- The ECP/MBP-induced activation was dependent on calcium, temperature, and cellular metabolism, and was blocked by specific antibodies.
Conclusions:
- ECP and MBP are selective activators of human cardiac mast cells.
- These activated mast cells contribute to cardiac pathology observed in patients with eosinophilia.
Abstract:
Eosinophilia in humans is associated with eosinophil infiltration and cardiac localization of eosinophil granule proteins. Eosinophil cationic proteins are responsible for cardiac disease in some patients with eosinophilia. We have investigated the in vitro effect of four eosinophil granule proteins: eosinophil cationic protein (ECP), major basic protein (MBP), eosinophil-derived neurotoxin (EDN) and eosinophil peroxidase (EPO), on mast cells isolated from human cardiac tissue (HHMC). ECP and, to a lesser extent MBP (0.3-3 microM), but not EDN and EPO, stimulated the release of histamine and tryptase from HHMC. This release reaction induced by ECP and MBP was Ca(2+)- and temperature-dependent and was abolished by preincubation with anti-ECP and anti-MBP, respectively. The activation of HHMC by ECP and MBP was abolished by preincubation with 2-deoxy-D-glucose and antimycin A. These data demonstrate that some eosinophil cationic proteins, ECP and MBP, are selective activators of HHMC, thus contributing to the cardiac lesions in patients with eosinophilia.
Related Concept Videos
G-Protein Gated Ion Channels
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Heart Failure Drugs: Inotropic Agents

